Smadar Samira Shakked
Keine laufenden Positionen mehr
Profil
Smadar Samira Shakked worked as a Senior Vice President-Finance at Quark Pharmaceuticals, Inc. from 1997 to 2010.
She holds an MBA from Tel-Aviv University and an undergraduate degree from The Hebrew University of Jerusalem.
Ehemalige bekannte Positionen von Smadar Samira Shakked
| Unternehmen | Position | Ende |
|---|---|---|
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Finanzdirektor/CFO | 27.09.2010 |
Ausbildung von Smadar Samira Shakked
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Tel-Aviv University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |